Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerActive Not Recruiting
NCT05132582Phase 3Updated Jul 22, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
HER2 Positive Breast Cancer
United States, Australia, Austria, Belgium, Brazil +18 more
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D MutationRecruiting
NCT06179160Phase 1Updated Jul 22, 2026
Sponsor: Incyte Corporation
Solid Tumors
United States, Australia, Belgium, Canada, France +3 more
Research on the Efficacy and Mechanism of Shouhui Tongbian Capsules in Treating Postoperative Constipation of Benign Anal and Rectal Diseases Based on Gut Microbiota AnalysisNot Yet Recruiting
NCT07648394Phase 1, Phase 2Updated Jul 22, 2026
Sponsor: China-Japan Friendship Hospital
Intestinal Flora · Anorectal Diseases · Surgery · Constipation
China
A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4Recruiting
NCT06078553N/AUpdated Jul 22, 2026
Sponsor: argenx
Congenital Myasthenic Syndrome
United States, Austria, Belgium, Brazil, Canada +7 more
Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular DystrophyActive Not Recruiting
NCT04281485Phase 3Updated Jul 22, 2026
Sponsor: Pfizer
Duchenne Muscular Dystrophy
United States, Australia, Belgium, Canada, France +10 more
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsActive Not Recruiting
NCT04521686Phase 1Updated Jul 22, 2026
Sponsor: Eli Lilly and Company
Cholangiocarcinoma · Chondrosarcoma · Glioma · Any Solid Tumor
United States, Australia, France, Hong Kong, Japan +4 more
A Study of PF-08046054/SGN-PDL1V in Advanced Solid TumorsRecruiting
NCT05208762Phase 1Updated Jul 22, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Carcinoma, Non-Small-Cell Lung · Squamous Cell Carcinoma of the Head and Neck · Esophageal Squamous Cell Carcinoma · Triple Negative Breast Neoplasms
United States, Belgium, Canada, China, France +6 more
Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).Completed
NCT04303780Phase 3Updated Jul 22, 2026
Sponsor: Amgen
KRAS p, G12c Mutated /Advanced Metastatic NSCLC
United States, Australia, Belgium, Brazil, Canada +18 more
Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS)Completed
NCT04607005Phase 3Updated Jul 22, 2026
Sponsor: GlaxoSmithKline
Nasal Polyps
Japan
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsRecruiting
NCT07422480Phase 3Updated Jul 22, 2026
Sponsor: Takeda
Myelodysplastic Syndrome · Anemia
United States, Argentina, Australia, Belgium, Brazil +23 more
Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)Active Not Recruiting
NCT07157605N/AUpdated Jul 22, 2026
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Pancreatic Cancer Resectable · Pancreatectomy
China, Greece, Italy, Japan, Netherlands +3 more
Study of INCA036978 in Participants With Myeloproliferative NeoplasmsRecruiting
NCT07441694Phase 1Updated Jul 22, 2026
Sponsor: Incyte Corporation
Myeloproliferative Neoplasms
United States, Australia, Belgium, Canada, France +6 more
A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D VirusCompleted
NCT04535544Phase 2Updated Jul 22, 2026
Sponsor: Janssen Research & Development, LLC
Hepatitis D, Chronic
United States, Australia, Brazil, China, France +10 more
A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisCompleted
NCT03896581Phase 3Updated Jul 22, 2026
Sponsor: UCB Biopharma SRL
Psoriatic Arthritis
United States, Australia, Canada, Czechia, Germany +6 more
Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C MutationCompleted
NCT05198934Phase 3Updated Jul 22, 2026
Sponsor: Amgen
Colorectal Cancer (CRC)
United States, Australia, France, Germany, Greece +7 more
Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care SettingActive Not Recruiting
NCT06712563N/AUpdated Jul 22, 2026
Sponsor: AstraZeneca
Pulmonary Disease, Chronic Obstructive
Canada, Germany, Greece, Italy, Japan +2 more
A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisCompleted
NCT03895203Phase 3Updated Jul 22, 2026
Sponsor: UCB Biopharma SRL
Psoriatic Arthritis
United States, Australia, Belgium, Canada, Czechia +9 more
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal CancerRecruiting
NCT05253651Phase 3Updated Jul 22, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms
United States, Argentina, Australia, Austria, Belgium +20 more
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)Recruiting
NCT06371417Phase 1Updated Jul 22, 2026
Sponsor: Chugai Pharmaceutical
Antiphospholipid Syndrome (APS) · Bullous Pemphigoid (BP) · Behçet's Syndrome (BS) · Dermatomyositis (DM)
United States, Australia, Austria, Bulgaria, Canada +15 more
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2Recruiting
NCT04879329Phase 2Updated Jul 22, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Urothelial Carcinoma
United States, Argentina, Australia, Belgium, Canada +7 more
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKETerminated
NCT05746559Phase 3Updated Jul 22, 2026
Sponsor: Alexion Pharmaceuticals, Inc.
Chronic Kidney Disease · CKD · Cardiac Disease · Cardiopulmonary Bypass
United States, Argentina, Australia, Brazil, Canada +15 more
Pilot Cluster RCT of an Indirect Contact Mental Health Literacy Program for 5th-Grade StudentsCompleted
NCT07324265NAUpdated Jul 22, 2026
Sponsor: Tokyo University
Mental Health Literacy · Stigma (Social Distance) · Help-seeking Intention
Japan
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)Active Not Recruiting
NCT05060016Phase 2Updated Jul 22, 2026
Sponsor: Amgen
Relapsed/Refractory Small Cell Lung Cancer
United States, Austria, Belgium, Denmark, France +13 more
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in CombinationsRecruiting
NCT06892522Phase 1, Phase 2Updated Jul 21, 2026
Sponsor: AbbVie
Multiple Myeloma
United States, Australia, Israel, Japan, Norway +1 more
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisRecruiting
NCT07250802Phase 3Updated Jul 21, 2026
Sponsor: Takeda
Plaque Psoriasis
United States, China, Germany, Italy, Japan +2 more

Previous page Next page